홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Pivalic anhydride → N-(7-(4-cyanoanilino)-1,2-dihydro-1-oxobenzo[f]quinazolin-3-yl)pivalamide

HRID 381612
인쇄

반응식

HRID 381612 반응식
[C:1]([C:3]1[CH:31]=[CH:30][C:6]([NH:7][C:8]2[C:21]3[CH2:20][CH2:19][C:18]4[N:17]=[C:16]([NH:22][C:23](=[O:28])[C:24]([CH3:27])([CH3:26])[CH3:25])[NH:15][C:14](=[O:29])[C:13]=4[C:12]=3[CH:11]=[CH:10][CH:9]=2)=[CH:5][CH:4]=1)#[N:2].C(OC(=O)C(C)(C)C)(=O)C(C)(C)C>[Pd].COCCOCCOC>[C:1]([C:3]1[CH:31]=[CH:30][C:6]([NH:7][C:8]2[C:21]3[CH:20]=[CH:19][C:18]4[N:17]=[C:16]([NH:22][C:23](=[O:28])[C:24]([CH3:27])([CH3:26])[CH3:25])[NH:15][C:14](=[O:29])[C:13]=4[C:12]=3[CH:11]=[CH:10][CH:9]=2)=[CH:5][CH:4]=1)#[N:2]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 2

HCID 15234Pivalic anhydrideHCID 135838113N-(7-(4-cyanoanilino)-1,2,5,6-tetrahydro-1-oxobenzo[f]quinazolin-3-yl)pivalamide

생성물 1

HCID 135838112N-(7-(4-cyanoanilino)-1,2-dihydro-1-oxobenzo[f]quinazolin-3-yl)pivalamide수율 57.6%

시약·촉매·용매 2

HCID 23938Palladium촉매HCID 8150Diglyme용매
2회

실험 절차

To a solution of sodium ethoxide, prepared by reacting sodium (0.28 g, 12 mmol) with ethanol(6 ml), was added guanidine hydrochloride (1.2 g, 12 mmol) and the mixture was briefly stirred at reflux. A solution of methyl 5-(N-(4-cyanophenyl)-2,2,2-trifluoroacetamido)-3,4-dihydro-2-hydroxy-1-naphthalene carboxylate (0.63 g, 1.5 mmol) in ethanol (6 ml) was added and the reaction mixture was stirred at reflux under nitrogen for 18 hours. The solution was diluted with water (50 ml), neutralized with acetic acid, and the resulting precipitate filtered and dried at 110° C. under reduced pressure. A solution of the solid in pivalic anhydride (10 ml) was refluxed for 5 minutes and then concentrated under high vacuum. The residue was eluted on silica gel (30 g) with ethyl acetate:methylene chloride (1:9) and the resulting solid recrystallized from diethyl ether, the slurry diluted with hexane, filtered, and the solid dried at 100° C. under reduced pressure to give N-(7-(4-cyanoanilino)-1,2,5,6-tetrahydro-1-oxobenzo[f]quinazolin-3-yl)pivalamide (0.48 g). 1H NMR (DMSO-d6, 200 MHz) δ: 1.23 (s, 9H, t-butyl), 2.67 (s, 4H, ArCH2's), 6.68 (d, J=9 Hz, 2H, Ar), 7.10 (d, J=8 Hz, 1H, Ar), 7.26 (t, J=8 Hz, 1H, Ar), 7.50 (d, J=9 Hz, 2H, Ar), 8.38 (d, J=8 Hz, 1H, Ar), 8.53 (s, 1H, C7—NH), 11.28 (br s, 1H, N2H), 12.16 (br s, 1H, C3—NH). A solution of the pivalamide (0.15 g) and 10% palladium on carbon (70 mg) in diglyme (5 ml) was stirred at reflux under nitrogen for 10 hours. Pivalic anhydride (2×0.5 ml, 4.9 mmol) was added at 5 and 9 hours. The solution was diluted with diglyme (15 ml), filtered hot through celite, and concentrated under high vacuum. The residue was purified by chromatography on silica gel (15 g) eluting with ethyl acetate:methylene chloride (1:9) and then recrystallization from methanol. The solid was filtered and dried at 90° C. under reduced pressure to give N-(7-(4-cyanoanilino)-1,2-dihydro-1-oxobenzo[f]quinazolin-3-yl)pivalamide (86 mg). 1H NMR (DMSO-d6, 200 MHz) δ: 1.26 (s, 9H, t-butyl), 6.85 (d, J=9 Hz, 2H, Ar), 7.49-7.60 (m, 4H, Ar), 7.72 (t, J=8 Hz, 1H, Ar); 8.29 (d, J=9 Hz, 1H, Ar); 9.07 (s, 1H, C7—NH), 9.61 (d, J=9 Hz, 1H, Ar), 11.25 (br s, 1H, N2H), 12.32 (br s, 1H, C3—NH). Mass spectrum (CI—CH4) 412 (M+1, 100%). Anal. Calculated for C24H21N5O2.17/100H2O: C, 69.54; H, 5.19; N, 16.89. Found: C, 69.56; H, 5.23; N, 16.88.

후처리

  1. temperatureat reflux under nitrogen for 10 hours
  2. filtrationfiltered hot through celite
  3. concentrationconcentrated under high vacuum
  4. customThe residue was purified by chromatography on silica gel (15 g)
  5. washeluting with ethyl acetate:methylene chloride (1:9)
  6. customrecrystallization from methanol
  7. filtrationThe solid was filtered
  8. customdried at 90° C. under reduced pressure

출처 및 근거

ORD 기록
ord-c3a6297c28a94f1cae45f1db21519457
출처 데이터셋
uspto-grants-2001_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06306865B1

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트